Citations (137)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Sachiyo Yoshio & Tatsuya Kanto. (2021) Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease. Immunological Medicine 44:3, pages 175-186.
Read now
Read now
Marlene Christina Nielsen, Morten Nørgaard Andersen, Henning Grønbæk, Thomas Damgaard Sandahl & Holger Jon Møller. (2020) Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease. Scandinavian Journal of Gastroenterology 55:5, pages 588-596.
Read now
Read now
Cecilie Brøckner Siggaard, Konstantin Kazankov, Sidsel Rødgaard-Hansen, Holger J. Møller, Mhairi C. Donnelly, Kenneth J. Simpson & Henning Grønbaek. (2019) Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose. Scandinavian Journal of Gastroenterology 54:5, pages 623-632.
Read now
Read now
Line Dam Heftdal, Anne Gitte Loft, Oliver Hendricks, Alice Ashouri Christiansen, Berit Schiøttz-Christensen, Bodil Arnbak, Anne Grethe Jurik, René Østgård, Bent Winding Deleuran, Holger Jon Møller & Stinne Ravn Greisen. (2018) Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis. Scandinavian Journal of Clinical and Laboratory Investigation 78:6, pages 483-489.
Read now
Read now
Tea Lund Laursen, Cecilie Brøckner Siggard, Konstantin Kazankov, Thomas Damgaard Sandahl, Holger Jon Møller, Adrian Ong, Mark W. Douglas, Jacob George, Britta Tarp, Lena Hagelskjaer Kristensen, Alex Lund Laursen, Akira Hiramatsu, Takashi Nakahara, Kazuaki Chayama & Henning Grønbaek. (2018) Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology. Scandinavian Journal of Gastroenterology 53:8, pages 986-993.
Read now
Read now
Sidsel Rødgaard-Hansen, Alexis St. George, Konstantin Kazankov, Adrian Bauman, Jacob George, Henning Grønbæk & Holger Jon Møller. (2017) Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 77:7, pages 498-504.
Read now
Read now
Konstantin Kazankov, Anthony Rode, Kira Simonsen, Gerda Elisabeth Villadsen, Amanda Nicoll, Holger Jon Møller, Lucy Lim, Peter Angus, Ian Kronborg, Niranjan Arachchi, Alexandra Gorelik, Danny Liew, Hendrik Vilstrup, Jan Frystyk & Henning Grønbæk. (2016) Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 76:1, pages 64-73.
Read now
Read now
Line Nederby, Anne S. Roug, Signe S. Knudsen, Anni Skovbo, Eigil Kjeldsen, Holger J. Moller & Marianne Hokland. (2015) Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 56:11, pages 3219-3221.
Read now
Read now
Holger J. Møller. (2012) Soluble CD163. Scandinavian Journal of Clinical and Laboratory Investigation 72:1, pages 1-13.
Read now
Read now
Troels Bygum Knudsen, Klaus Larsen, Thomas Birk Kristiansen, Holger Jon Møller, Michael Tvede, Jesper Eugen-Olsen & Gitte Kronborg. (2007) Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: Comparison with CRP and procalcitonin. Scandinavian Journal of Infectious Diseases 39:6-7, pages 542-553.
Read now
Read now
Camilla S. Kronborg, Ulla Breth Knudsen, Søren K. Moestrup, Jim Allen, Erik Vittinghus & Holger J. Møller. (2007) Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin. Acta Obstetricia et Gynecologica Scandinavica 86:9, pages 1041-1046.
Read now
Read now
H. J. MØLLER, P. HYLTOFT PETERSEN, L. REJNMARK & S. K. MOESTRUP. (2003) Biological variation of soluble CD163. Scandinavian Journal of Clinical and Laboratory Investigation 63:1, pages 15-22.
Read now
Read now
Articles from other publishers (125)
Kristian W. Antonsen, Anne G. Jensen, Mikkel Carstensen, Lene N. Nejsum, Boe S. Sorensen, Anders Etzerodt, Søren K. Moestrup & Holger J. Møller. (2024) Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade. European Journal of Immunology.
Crossref
Crossref
Kristian W. Antonsen, Henriette N. Friis, Boe S. Sorensen, Anders Etzerodt, Søren K. Moestrup & Holger J. Møller. (2023) Comparison of culture media reveals that non‐essential amino acids strongly affect the phenotype of human monocyte‐derived macrophages. Immunology 170:3, pages 344-358.
Crossref
Crossref
Matthias Egger, Angela Horvath, Florian Prüller, Peter Fickert, Malcolm Finkelman, Lisa Kriegl, Henning Grønbæk, Holger Jon Møller, Juergen Prattes, Robert Krause, Martin Hoenigl & Vanessa Stadlbauer. (2023) Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study. Liver International 43:9, pages 1975-1983.
Crossref
Crossref
Bo L. HøngeMorten N Andersen, Mikkel S. Petersen, Sanne JespersenCandida Medina, David DS. Té, Bertram Kjerulff, Alex L. LaursenHolger J. Møller, Christian Wejse, Henrik KrarupBjarne K. Møller & Christian Erikstrup. (2023) Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection. AIDS.
Crossref
Crossref
Laura Louise Fosgrau Hergel, Katrine Kielsen, Sarah Weischendorff, Marianne Ifversen, Nakisa Kamari-Kany, Holger Jon Møller, Søren Rittig, Henning Grønbæk & Klaus Müller. (2023) The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation 58:5, pages 587-589.
Crossref
Crossref
Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen, Marlene Christina Nielsen, Astrid Højmark Andersen, Peter Ott, Sabine Becker, Henning Glerup, Lise Svenningsen, Martin Eivindson, Linda Kornerup, Niels Bjørndal Kjeldsen, Anders Neumann, Holger Jon Møller, Peter Jepsen & Henning Grønbæk. (2023) The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology Communications 7:4.
Crossref
Crossref
Mathilde Ørbæk, Rosa Maja Møhring Gynthersen, Helene Mens, Christian Brandt, Christian Stenør, Lothar Wiese, Åse Bengaard Andersen, Holger J. Møller & Anne-Mette Lebech. (2023) Cerebrospinal fluid levels of the macrophage-specific biomarker sCD163 are diagnostic for Lyme neuroborreliosis: An observational cohort study. Clinica Chimica Acta 543, pages 117299.
Crossref
Crossref
Ninna Aggerholm-Pedersen, Henriette Nymark Friis, Thomas Baad-Hansen, Holger Jon Møller & Birgitte Sandfeld-Paulsen. (2023) Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients. Cancers 15:5, pages 1544.
Crossref
Crossref
Camilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, Daniel El Fassi, Holger J. Møller, Jørgen A. Lindholm Kurtzhals, Bjarne Styrishave, Caroline Kistorp, Christian Tuxen, Mikael K. Poulsen, Jens Faber, Lars Køber, Finn Gustafsson, Jacob E. Møller, Morten Schou & Jesper Jensen. (2022)
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire
HF
trial
. European Journal of Heart Failure 25:2, pages 226-234.
Crossref
Crossref
Maria Kløjgaard Skytthe, Felix Boel Pedersen, Charlotte Wilhelmina Wernberg, Vineesh Indira Chandran, Aleksander Krag, Tina Di Caterino, Samuel Coelho Mandacaru, Blagoy Blagoev, Mette Munk Lauridsen, Sönke Detlefsen, Jonas Heilskov Graversen & Søren Kragh Moestrup. (2023) Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163. Gastro Hep Advances 2:5, pages 711-720.
Crossref
Crossref
Peter Durda, Laura M. Raffield, Ethan M. Lange, Nels C. Olson, Nancy Swords Jenny, Mary Cushman, Pia Deichgraeber, Niels Grarup, Anna Jonsson, Torben Hansen, Josyf C. Mychaleckyj, Bruce M. Psaty, Alex P. Reiner, Russell P. Tracy & Leslie A. Lange. (2022) Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study. Journal of the American Heart Association 11:21.
Crossref
Crossref
Victoria Cairoli, Elena De Matteo, Paola Casciato, Beatriz Ameigeiras, María Victoria Preciado & Pamela Valva. (2022) The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects. PLOS ONE 17:7, pages e0270911.
Crossref
Crossref
Yoanna V. Vladimirova, Marie K. Mølmer, Kristian W. Antonsen, Niels Møller, Nikolaj Rittig, Marlene C. Nielsen & Holger J. Møller. (2022) A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα). Biomolecules 12:7, pages 937.
Crossref
Crossref
Nina Kimer, Mads Meldgaard, Ole Hamberg, Thit Mynster Kronborg, Allan M. Lund, Holger Jon Møller, Flemming Bendtsen & Henriette Ytting. (2022) The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. PLOS ONE 17:3, pages e0264278.
Crossref
Crossref
Konstantin Kazankov, Kirstine Nyvold Bojsen‐Møller, Holger Jon Møller, Sten Madsbad & Henning Grønbæk. (2022) Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass. Physiological Reports 10:2.
Crossref
Crossref
Morten N. Andersen, Niels F. Andersen, Kristina L. Lauridsen, Anders Etzerodt, Boe S. Sorensen, Niels Abildgaard, Trine Plesner, Marianne Hokland & Holger J. Møller. (2021) STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS. Cancer Immunology, Immunotherapy 71:1, pages 177-187.
Crossref
Crossref
Zhila Semnani‐Azad, Sonia Blanco Mejia, Philip W. Connelly, Richard P. Bazinet, Ravi Retnakaran, David J. A. Jenkins, Stewart B. Harris & Anthony J. Hanley. (2021) The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review. Obesity Reviews 22:9.
Crossref
Crossref
Yue Zhang, Chenkai Huang, Yuan Nie, Qi Liu, Nanxi Xiao, Linxiang Liu & Xuan Zhu. (2021) Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Frontiers in Medicine 8.
Crossref
Crossref
Nikolaj Worm Ørntoft, Michel Blé, Anna Baiges, Jose Ferrusquia, Virginia Hernández-Gea, Fanny Turon, Marta Magaz, Søren Møller, Holger Jon Møller, Juan Carlos Garcia-Pagan & Henning Gronbaek. (2021) Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension. Frontiers in Physiology 12.
Crossref
Crossref
Sara Konstantin Nissen, Sara Almeida Ferreira, Marlene Christina Nielsen, Claudia Schulte, Kalpana Shrivastava, Dorle Hennig, Anders Etzerodt, Jonas Heilskov Graversen, Daniela Berg, Walter Maetzler, Anne Panhelainen, Holger Jon Møller, Kathrin Brockmann & Marina Romero‐Ramos. (2020)
Soluble
CD163
Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
. Movement Disorders 36:4, pages 963-976.
Crossref
Crossref
Anne J. Nielsen, Marlene C. Nielsen, Henrik Birn, Per Ivarsen, Holger J. Møller & Claus V. B. Hviid. (2021) Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance. Clinical Chemistry and Laboratory Medicine (CCLM) 59:4, pages 701-709.
Crossref
Crossref
Lars BossenMette VesterhusJohannes R. HovMartti FärkkiläWilliam M. RosenbergHolger J. MøllerKirsten M. BobergTom H. KarlsenHenning Grønbæk. (2021) Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis. Clinical and Translational Gastroenterology 12:3, pages e00315.
Crossref
Crossref
Sidsel StøyTea Lund LaursenLotte Lindgreen EriksenHenning GrønbækHendrik VilstrupThomas Damgaard Sandahl. (2021) No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation. Clinical and Translational Gastroenterology 12:2, pages e00306.
Crossref
Crossref
Tea Lund Laursen, Ida Falk Villesen, Diana Julie Leeming, Morten Asser Karsdal, Christina Sølund, Britta Tarp, Lena Hagelskjær Kristensen, Charlotte Henneberg Holmboe, Peter Leutscher, Alex Lund Laursen, Natasja Stæhr Gudmann & Henning Grønbæk. (2020) Altered balance between collagen formation and degradation after successful direct‐acting antiviral therapy of chronic hepatitis C. Journal of Viral Hepatitis 28:2, pages 236-244.
Crossref
Crossref
Konstantin Kazankov, Chiara Rosso, Ramy Younes, Angelo Armandi, Hannes Hagström, Holger Jon Møller, Per Stål, Elisabetta Bugianesi & Henning Grønbæk. (2020) Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease. Frontiers in Medicine 7.
Crossref
Crossref
Emilie Glavind, Daniel N. Gotthardt, Jan Pfeiffenberger, Thomas Damgaard Sandahl, Teodora Bashlekova, Gro Linno Willemoe, Jane Preuss Hasselby, Karl Heinz Weiss, Holger Jon Møller, Hendrik Vilstrup, William M. Lee, Michael L. Schilsky, Peter Ott & Henning Grønbæk. (2020) The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Kinneret Tenenbaum-Gavish, Adi Sharabi-Nov, Dana Binyamin, Holger Jon Møller, David Danon, Lihi Rothman, Eran Hadar, Ana Idelson, Ida Vogel, Omry Koren, Kypros H. Nicolaides, Henning Gronbaek & Hamutal Meiri. (2020) First trimester biomarkers for prediction of gestational diabetes mellitus. Placenta 101, pages 80-89.
Crossref
Crossref
Amalie R. Lanng, Lærke S. Gasbjerg, Natasha C. Bergmann, Matthew P. Gillum, Jens F. Rehfeld, Mads M. Helsted, Holger J. Møller, Henning Grønbæk, Tina Vilsbøll & Filip K. Knop. (2020) The effect of acute intragastric vs. intravenous alcohol administration on inflammation markers, blood lipids and gallbladder motility in healthy men. Alcohol 87, pages 29-37.
Crossref
Crossref
Daniëlle Krijgsman, Natasja L. De Vries, Morten N. Andersen, Anni Skovbo, Rob A.E.M. Tollenaar, Holger J. Møller, Marianne Hokland & Peter J.K. Kuppen. (2020) CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood. International Journal of Molecular Sciences 21:16, pages 5925.
Crossref
Crossref
Tea Lund Laursen, Thomas Damgaard Sandahl, Konstantin Kazankov, Peter Lykke Eriksen, Lena Hagelskjær Kristensen, Charlotte Henneberg Holmboe, Alex Lund Laursen, Hendrik Vilstrup & Henning Grønbæk. (2020) Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 319:2, pages G151-G156.
Crossref
Crossref
Signe Wiese, Andrei Voiosu, Jens D. Hove, Karen V. Danielsen, Theodor Voiosu, Henning Grønbæk, Holger Jon Møller, Federica Genovese, Alexander Lynge Reese‐Petersen, Rajeshwar P. Mookerjee, Jens Otto Clemmesen, Jens Peter Gøtze, Ove Andersen, Søren Møller & Flemming Bendtsen. (2020) Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy. Alimentary Pharmacology & Therapeutics 52:2, pages 340-350.
Crossref
Crossref
Tea L Laursen, Thomas D Sandahl, Konstantin Kazankov, Jacob George & Henning Grønbæk. (2020) Liver-related effects of chronic hepatitis C antiviral treatment. World Journal of Gastroenterology 26:22, pages 2931-2947.
Crossref
Crossref
Lars Bossen, Paola Rebora, Francesca Bernuzzi, Peter Jepsen, Alessio Gerussi, Pietro Andreone, Andrea Galli, Benedetta Terziroli, Domenico Alvaro, Giancarlo Labbadia, Chiara Aloise, Leonardo Baiocchi, Edoardo Giannini, Ludovico Abenavoli, Pierluigi Toniutto, Fabio Marra, Marco Marzioni, Grazia Niro, Annarosa Floreani, Holger J. Møller, Maria G. Valsecchi, Marco Carbone, Henning Grønbæk & Pietro Invernizzi. (2020) Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis. Liver International 40:6, pages 1408-1414.
Crossref
Crossref
Sarah L. Kvorning, Marlene C. Nielsen, Niels F. Andersen, Marianne Hokland, Morten N. Andersen & Holger J. Møller. (2020) Circulating extracellular vesicle‐associated CD163 and CD206 in multiple myeloma. European Journal of Haematology 104:5, pages 409-419.
Crossref
Crossref
Vanessa Stadlbauer, Irina Komarova, Ingeborg Klymiuk, Marija Durdevic, Alexander Reisinger, Andreas Blesl, Florian Rainer & Angela Horvath. (2020) Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis. Liver International 40:4, pages 866-877.
Crossref
Crossref
Zhila Semnani-Azad, Philip W Connelly, Luke W Johnston, Ravi Retnakaran, Stewart B Harris, Bernard Zinman & Anthony J Hanley. (2020) The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function. The Journal of Clinical Endocrinology & Metabolism 105:3, pages e285-e294.
Crossref
Crossref
Andreas Brønden, Emil List Larsen, Kristian Karstoft, Trine Henriksen, Tina Vilsbøll, Henrik Enghusen Poulsen & Filip Krag Knop. (2020) Changes in oxidative nucleic acid modifications and inflammation following one-week treatment with the bile acid sequestrant sevelamer: Two randomised, placebo-controlled trials. Journal of Diabetes and its Complications 34:2, pages 107446.
Crossref
Crossref
Tea Lund Laursen, Cecilie Brøckner Siggaard, Konstantin Kazankov, Thomas Damgaard Sandahl, Holger Jon Møller, Britta Tarp, Lena Hagelskjær Kristensen, Alex Lund Laursen, Peter Leutscher & Henning Grønbæk. (2019) Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C. Journal of Viral Hepatitis 27:1, pages 28-35.
Crossref
Crossref
Marlene C. Nielsen, Morten N. Andersen & Holger J. Møller. (2019)
Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages
in vitro
. Immunology 159:1, pages 63-74.
Crossref
Crossref
Chiara Rosso, Konstantin Kazankov, Ramy Younes, Saeed Esmaili, Milena Marietti, Marco Sacco, Fabrizia Carli, Melania Gaggini, Federico Salomone, Holger Jon Møller, Maria Lorena Abate, Hendrik Vilstrup, Amalia Gastaldelli, Jacob George, Henning Grønbæk & Elisabetta Bugianesi. (2019) Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. Journal of Hepatology 71:5, pages 1012-1021.
Crossref
Crossref
Marlene Christina Nielsen, Morten Nørgaard Andersen, Nikolaj Rittig, Sidsel Rødgaard-Hansen, Henning Grønbæk, Søren Kragh Moestrup, Holger Jon Møller & Anders Etzerodt. (2019) The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms. Journal of Leukocyte Biology 106:5, pages 1129-1138.
Crossref
Crossref
Peter Lykke Eriksen, Michael Sørensen, Henning Grønbæk, Stephen Hamilton-Dutoit, Hendrik Vilstrup & Karen Louise Thomsen. (2019) Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions. Clinics and Research in Hepatology and Gastroenterology 43:5, pages 551-560.
Crossref
Crossref
Sine Knorr, Birgitte Bytoft, Zuzana Lohse, Anne B. Boisen, Tine D. Clausen, Rikke B. Jensen, Peter Damm, Henning Beck-Nielsen, Jens J. Holst, Bolette Hartmann, Holger J. Møller, Kurt Højlund, Claus H. Gravholt & Dorte M. Jensen. (2019) Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study). Diabetes Care 42:8, pages 1560-1568.
Crossref
Crossref
Rahim Mohammad Naimi, Mark Hvistendahl, Nikolaj Nerup, Rikard Ambrus, Michael Patrick Achiam, Lars Bo Svendsen, Henning Grønbæk, Holger Jon Møller, Hendrik Vilstrup, Adam Steensberg & Palle Bekker Jeppesen. (2019) Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial. eBioMedicine 46, pages 444-451.
Crossref
Crossref
Karen L. Thomsen, Francis P. Robertson, Peter Holland-Fischer, Brian R. Davidson, Rajeshwar P. Mookerjee, Holger J. Møller, Rajiv Jalan & Henning Grønbæk. (2019) The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. Journal of Clinical and Experimental Hepatology 9:3, pages 302-311.
Crossref
Crossref
Mads Svart, Nikolaj Rittig, Niels Møller, Holger J Møller & Henning Gronbaek. (2018)
Soluble
CD
163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
. Journal of Diabetes Investigation 10:1, pages 67-72.
Crossref
Crossref
Jessica Björklund, Tea Lund Laursen, Thomas Damgaard Sandahl, Holger Jon Møller, Hendrik Vilstrup, Peter Ott & Henning Grønbæk. (2018) High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Konstantin Kazankov, Anna Alisi, Holger J. Møller, Rita De Vito, Søren Rittig, Birgitte Mahler, Valerio Nobili & Henning Grønbæk. (2018) Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 67:5, pages 635-642.
Crossref
Crossref
Nina Kimer, Natasja Stæhr Gudmann, Julie Steen Pedersen, Søren Møller, Mette Juul Nielsen, Diana Julie Leeming, Morten Asser Karsdal, Holger Jon Møller, Flemming Bendtsen & Henning Grønbæk. (2018) No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial. PLOS ONE 13:9, pages e0203200.
Crossref
Crossref
Sidsel Støy, Thomas Damgaard Sandahl, Anne Louise Hansen, Bent Deleuran, Thomas Vorup-Jensen, Hendrik Vilstrup & Tue Wenzel Kragstrup. (2018) Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis. Clinical and Translational Gastroenterology 9:6.
Crossref
Crossref
F. Rainer, A. Horvath, T. D. Sandahl, B. Leber, B. Schmerboeck, A. Blesl, A. Groselj‐Strele, R. E. Stauber, P. Fickert, P. Stiegler, H. J. Møller, H. Grønbæk & V. Stadlbauer. (2017)
Soluble
CD
163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation
. Alimentary Pharmacology & Therapeutics 47:5, pages 657-664.
Crossref
Crossref
Tea Lund Laursen, Grace Lai‐Hung Wong, Konstantin Kazankov, Thomas Sandahl, Holger Jon Møller, Stephen Hamilton‐Dutoit, Jacob George, Henry Lik‐Yuen Chan & Henning Grønbæk. (2018) Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. Journal of Gastroenterology and Hepatology 33:2, pages 484-491.
Crossref
Crossref
Mikkel Carstensen Gjelstrup, Morten Stilund, Thor Petersen, Holger Jon Møller, Eva Lykke Petersen & Tove Christensen. (2017) Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunology & Cell Biology 96:2, pages 160-174.
Crossref
Crossref
Nikolaj Rittig, Mads Svart, Niels Jessen, Niels Møller, Holger J Møller & Henning Grønbæk. (2018) Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial. Endocrine Connections 7:1, pages 107-114.
Crossref
Crossref
Karen Fjeldborg, Steen B. Pedersen, Holger J. Møller & Bjørn Richelsen. (2017) Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content. Surgery for Obesity and Related Diseases 13:9, pages 1515-1523.
Crossref
Crossref
Laurent Detzen, Steven C. Y. Chen, Bin Cheng, Panos N. Papapanou & Evanthia Lalla. (2017)
Increased levels of soluble
CD
163 in periodontitis patients
. Journal of Clinical Periodontology 44:6, pages 585-590.
Crossref
Crossref
Ditte M. Kirkegaard-Klitbo, Niels Mejer, Troels B. Knudsen, Holger J. Møller, Søren K. Moestrup, Susanne D. Poulsen, Gitte Kronborg & Thomas Benfield. (2017) Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection. AIDS 31:7, pages 981-988.
Crossref
Crossref
Anders Etzerodt, Ronan M. G. Berg, Ronni R. Plovsing, Morten N. Andersen, Magali Bebien, Mohamed Habbeddine, Toby Lawrence, Holger J. Møller & Søren K. Moestrup. (2017) Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma. Scientific Reports 7:1.
Crossref
Crossref
Holger Jon Møller, Konstantin Kazankov, Sidsel Rødgaard-Hansen, Marlene Christina Nielsen, Thomas D. Sandahl, Hendrik Vilstrup, Søren Kragh Moestrup & Henning Grønbæk. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease
321
348
.
Tamas Tornai, Zsuzsanna Vitalis, Nora Sipeki, Tamas Dinya, David Tornai, Peter Antal‐Szalmas, Zsolt Karanyi, Istvan Tornai & Maria Papp. (2016)
Macrophage activation marker, soluble
CD
163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection
. Liver International 36:11, pages 1628-1638.
Crossref
Crossref
H. Grønbæk, M. Kreutzfeldt, K. Kazankov, N. Jessen, T. Sandahl, S. Hamilton‐Dutoit, H. Vilstrup & H. J. Møller. (2016) Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 44:10, pages 1062-1070.
Crossref
Crossref
Troels Bygum Knudsen, Gideon Ertner, Janne Petersen, Holger Jon Møller, Søren K. Moestrup, Jesper Eugen-Olsen, Gitte Kronborg & Thomas Benfield. (2016) Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1–Infected Individuals. Journal of Infectious Diseases 214:8, pages 1198-1204.
Crossref
Crossref
Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, Chiara Rosso, Elisabetta Bugianesi, Ezio David, Ramy Ibrahim Kamal Jouness, Saeed Esmaili, Mohammed Eslam, Duncan McLeod, Bo Martin Bibby, Hendrik Vilstrup, Jacob George & Henning Grønbæk. (2016)
The macrophage activation marker
sCD
163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease
. Liver International 36:10, pages 1549-1557.
Crossref
Crossref
Jeroen Melief, Jan W. Koper, Erik Endert, Holger J. Møller, Jörg Hamann, Bernard M. Uitdehaag & Inge Huitinga. (2016) Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis. Journal of Neuroimmunology 299, pages 84-89.
Crossref
Crossref
Morten Stilund, Mikkel Carstensen Gjelstrup, Tove Christensen, Holger Jon Møller & Thor Petersen. (2016) A multi‐biomarker follow‐up study of patients with multiple sclerosis. Brain and Behavior 6:9.
Crossref
Crossref
Emilie Glavind, Niels Kristian Aagaard, Henning Grønbæk, Holger Jon Møller, Nikolaj Worm Orntoft, Hendrik Vilstrup & Karen Louise Thomsen. (2016) Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. PLOS ONE 11:7, pages e0158388.
Crossref
Crossref
Bo L. HøngeMorten N. AndersenSanne JespersenCandida Medina, Faustino G. Correira, Martin R. JakobsenAlex LaursenChristian ErikstrupHolger J. MøllerChristian Wejse. (2016) Brief Report: Macrophage Activation in HIV-2–Infected Patients Is Less Affected by Antiretroviral Treatment—sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 72:3, pages 254-258.
Crossref
Crossref
T. D. Sandahl, R. McGrail, H. J. Møller, E. Reverter, S. Møller, F. Turon, V. Hernández‐Gea, F. Bendtsen, H. Vilstrup, J. C. Garcia‐Pagan & H. Grønbæk. (2016)
The macrophage activation marker
sCD
163 combined with markers of the Enhanced Liver Fibrosis (
ELF
) score predicts clinically significant portal hypertension in patients with cirrhosis
. Alimentary Pharmacology & Therapeutics 43:11, pages 1222-1231.
Crossref
Crossref
Henning Grønbæk, Sidsel Rødgaard-Hansen, Niels Kristian Aagaard, Vicente Arroyo, Søren K. Moestrup, Elisabet Garcia, Elsa Solà, Marco Domenicali, Salvatore Piano, Hendrik Vilstrup & Holger Jon Møller. (2016) Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). Journal of Hepatology 64:4, pages 813-822.
Crossref
Crossref
Wen-jing Xie, Hong-quan Yu, Yu Zhang, Qun Liu & Hong-mei Meng. (2016) CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage. Neural Regeneration Research 11:7, pages 1122.
Crossref
Crossref
Holger Jon Møller, Konstantin Kazankov, Sidsel Rødgaard-Hansen, Marlene Christina Nielsen, Thomas D. Sandahl, Hendrik Vilstrup, Søren Kragh Moestrup & Henning Grønbæk. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease
1
28
.
Konstantin Kazankov, Joan Tordjman, Holger Jon Møller, Hendrik Vilstrup, Christine Poitou, Pierre Bedossa, Jean‐Luc Bouillot, Karine Clement & Henning Grønbæk. (2015)
Macrophage activation marker soluble
CD
163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
. Journal of Gastroenterology and Hepatology 30:8, pages 1293-1300.
Crossref
Crossref
K. Kazankov, H. J. Møller, A. Lange, N. H. Birkebæk, P. Holland‐Fischer, J. Solvig, A. Hørlyck, K. Kristensen, S. Rittig, A. Handberg, H. Vilstrup & H. Grønbæk. (2014)
The macrophage activation marker s
CD
163 is associated with changes in
NAFLD
and metabolic profile during lifestyle intervention in obese children
. Pediatric Obesity 10:3, pages 226-233.
Crossref
Crossref
Morten Stilund, Mikkel Carstensen Gjelstrup, Thor Petersen, Holger Jon Møller, Peter Vestergaard Rasmussen & Tove Christensen. (2015) Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel. PLOS ONE 10:4, pages e0119681.
Crossref
Crossref
Andreas Knudsen, Anne Mette Fisker Hag, Annika Loft, Eric von Benzon, Sune H. Keller, Holger Jon Møller, Anne-Mette Lebech, Rasmus Sejersten Ripa & Andreas Kjær. (2015) HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study. Journal of Nuclear Cardiology 22:2, pages 372-380.
Crossref
Crossref
Jesper F. Højen, Thomas A. Rasmussen, Karen Lise D. Andersen, Anni A. Winckelmann, Rune R. Laursen, Jesper D. Gunst, Holger J. Møller, Mayumi Fujita, Lars Østergaard, Ole S. Søgaard, Charles A. Dinarello & Martin Tolstrup. (2015) Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir. Molecular Medicine 21:1, pages 337-345.
Crossref
Crossref
M. Kallestrup, H. J. Møller, H. Tankisi & H. Andersen. (2014)
Soluble
CD
163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function
. Diabetic Medicine 32:1, pages 54-61.
Crossref
Crossref
Karen Fjeldborg, Steen B. Pedersen, Holger J. Møller, Peter Rask, Allan Vestergaard Danielsen, Hans Stødkilde‐Jørgensen & Bjørn Richelsen. (2014)
Intrahepatic fat content correlates with soluble
CD
163 in relation to weight loss induced by
R
oux‐en‐
Y
gastric bypass
. Obesity 23:1, pages 154-161.
Crossref
Crossref
A. Dige, S. Støy, K. L. Thomsen, C. L. Hvas, J. Agnholt, J. F. Dahlerup, H. J. Møller & H. Grønbæk. (2014)
Soluble
CD
163, a Specific Macrophage Activation Marker, is Decreased by Anti‐
TNF
‐
α
Antibody Treatment in Active Inflammatory Bowel Disease
. Scandinavian Journal of Immunology 80:6, pages 417-423.
Crossref
Crossref
Thomas Damgaard Sandahl, Henning Grønbæk, Holger Jon Møller, Sidsel Støy, Karen Luise Thomsen, Anders Kirch Dige, Jørgen Agnholt, Stephen Hamilton-Dutoit, Steffen Thiel & Hendrik Vilstrup. (2014) Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study. American Journal of Gastroenterology 109:11, pages 1749-1756.
Crossref
Crossref
K. Fjeldborg, H. J. Moller, B. Richelsen & S. B. Pedersen. (2014) Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro. Journal of Molecular Endocrinology 53:2, pages 227-235.
Crossref
Crossref
Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, Bo Martin Bibby, Hendrik Vilstrup, Jacob George & Henning Grønbaek. (2014) Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology 60:2, pages 521-530.
Crossref
Crossref
Morten N. Andersen, Niels Abildgaard, Maciej B. Maniecki, Holger J. Møller & Niels F. Andersen. (2014)
Monocyte/macrophage‐derived soluble
CD
163: a novel biomarker in multiple myeloma
. European Journal of Haematology 93:1, pages 41-47.
Crossref
Crossref
Morten Stilund, Ann-Kathrin Reuschlein, Tove Christensen, Holger Jon Møller, Peter Vestergaard Rasmussen & Thor Petersen. (2014) Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis. PLoS ONE 9:6, pages e98588.
Crossref
Crossref
Anders G. Kjærgaard, Sidsel Rødgaard-Hansen, Anders Dige, Jan Krog, Holger J. Møller & Else Tønnesen. (2014) Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients. PLoS ONE 9:3, pages e92331.
Crossref
Crossref
Sidsel Rødgaard-Hansen, Aisha Rafique, Peter A. Christensen, Maciej B. Maniecki, Thomas D. Sandahl, Ebba Nexø & Holger Jon Møller. (2014) A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clinical Chemistry and Laboratory Medicine (CCLM) 52:3, pages 453-461.
Crossref
Crossref
Karen Fjeldborg, Steen B. Pedersen, Holger J. Møller, Tore Christiansen, Marianne Bennetzen & Bjørn Richelsen. (2014) Human Adipose Tissue Macrophages Are Enhanced but Changed to an Anti-Inflammatory Profile in Obesity. Journal of Immunology Research 2014, pages 1-10.
Crossref
Crossref
Anders Etzerodt, Mie Rostved Rasmussen, Pia Svendsen, Athena Chalaris, Jeanette Schwarz, Ian Galea, Holger Jon Møller & Søren Kragh Moestrup. (2014) Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages. Journal of Biological Chemistry 289:2, pages 778-788.
Crossref
Crossref
E. S. Andersen, S. Rødgaard-Hansen, B. Moessner, P. B. Christensen, H. J. Møller & Nina Weis. (2013) Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. European Journal of Clinical Microbiology & Infectious Diseases 33:1, pages 117-122.
Crossref
Crossref
Andreas Knudsen, Holger Jon Møller, Terese L Katzenstein, Jan Gerstoft, Niels Obel, Gitte Kronborg, Thomas Benfield, Andreas Kjaer & Anne-Mette Lebech. (2013) Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study. BMC Infectious Diseases 13:1.
Crossref
Crossref
Karen Fjeldborg, Tore Christiansen, Marianne Bennetzen, Holger J. Møller, Steen B. Pedersen & Bjørn Richelsen. (2013) The Macrophage‐Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary‐Induced Weight Loss. Obesity 21:12, pages 2437-2443.
Crossref
Crossref
Anders EtzerodtSøren K. Moestrup. (2013) CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects. Antioxidants & Redox Signaling 18:17, pages 2352-2363.
Crossref
Crossref
Catherine Ingels, Holger J. Møller, Troels K. Hansen, Pieter J. Wouters, Ilse Vanhorebeek & Greet Van den Berghe. (2012) Circulating Levels of the Shed Scavenger Receptor sCD163 and Association with Outcome of Critically Ill Patients. Journal of Clinical Immunology 33:3, pages 619-629.
Crossref
Crossref
Ratana Lim, Martha Lappas, Clyde Riley, Niels Borregaard, Holger J Moller, Nuzhat Ahmed & Gregory E Rice. (2013) Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer. Journal of Ovarian Research 6:1, pages 5.
Crossref
Crossref
Jesper Schou, Anne Tybjærg-Hansen, Holger J. Møller, Børge G. Nordestgaard & Ruth Frikke-Schmidt. (2012) ABC Transporter Genes and Risk of Type 2 Diabetes. Diabetes Care 35:12, pages 2600-2606.
Crossref
Crossref
H. Grønbæk, T. D. Sandahl, C. Mortensen, H. Vilstrup, H. J. Møller & S. Møller. (2012)
Soluble
CD
163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
. Alimentary Pharmacology & Therapeutics 36:2, pages 173-180.
Crossref
Crossref
T. Parkner, L. P. Sørensen, A. R. Nielsen, C. P. Fischer, B. M. Bibby, S. Nielsen, B. K. Pedersen & H. J. Møller. (2012) Soluble CD163: a biomarker linking macrophages and insulin resistance. Diabetologia 55:6, pages 1856-1862.
Crossref
Crossref
Maciej Bogdan Maniecki, Anders Etzerodt, Søren Kragh Moestrup, Holger Jon Møller & Jonas Heilskov Graversen. (2011) Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. Immunobiology 216:8, pages 882-890.
Crossref
Crossref
Holger J Møller, Ruth Frikke-Schmidt, Søren K Moestrup, Børge G Nordestgaard & Anne Tybjærg-Hansen. (2011) Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population. Clinical Chemistry 57:2, pages 291-297.
Crossref
Crossref
Anders Etzerodt, Maciej Bogdan Maniecki, Kirsten Møller, Holger Jon Møller & Søren Kragh Moestrup. (2010) Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. Journal of Leukocyte Biology 88:6, pages 1201-1205.
Crossref
Crossref
Holger Jon Møller, Marianne Jensby Nielsen, Maciej Bogdan Maniecki, Mette Madsen & Søren Kragh Moestrup. (2010) Soluble macrophage-derived CD163: A homogenous ectodomain protein with a dissociable haptoglobin–hemoglobin binding. Immunobiology 215:5, pages 406-412.
Crossref
Crossref
H.M. Willemsen, I.C.C. van der Horst, W. Nieuwland, R.J.H.A. Slart, C.J. Zeebregts, E. de Boef, J.H.N. Schuitemaker, F. Zijlstra & R.A. Tio. (2009) The diagnostic value of soluble CD163 in patients presenting with chest pain. Clinical Biochemistry 42:16-17, pages 1662-1666.
Crossref
Crossref
Trine O. JensenHenrik SchmidtHolger Jon MøllerMorten HøyerMaciej Bogdan ManieckiPia SjoegrenIb Jarle ChristensenTorben Steiniche. (2009) Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma. Journal of Clinical Oncology 27:20, pages 3330-3337.
Crossref
Crossref
Christian J. Terkelsen, Claus Oxvig, Bjarne L. Nørgaard, Simon Glerup, Tina S. Poulsen, Jens F. Lassen, Holger J. Møller, Leif Thuesen, Erling Falk, Torsten T. Nielsen & Henning R. Andersen. (2009) Temporal Course of Pregnancy-Associated Plasma Protein-A in Angioplasty-Treated ST-Elevation Myocardial Infarction Patients and Potential Significance of Concomitant Heparin Administration. The American Journal of Cardiology 103:1, pages 29-35.
Crossref
Crossref
Maciej Bogdan ManieckiHenrik HasleLennart Friis-HansenBirgitte Lausen, Ove Juul NielsenKnud Bendix, Søren Kragh Moestrup & Holger Jon Møller. (2008) Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. Blood 112:4, pages 1510-1514.
Crossref
Crossref
S Gaïni, S S Pedersen, O G Koldkjær, C Pedersen, S K Moestrup & H J Møller. (2008) New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clinical and Experimental Immunology 151:3, pages 423-431.
Crossref
Crossref
Holger Jon M?ller, Henning Gr?nb?k, Frank V. Schi?dt, Peter Holland-Fischer, Michael Schilsky, Santiago Munoz, Tarek Hassanein & William M. Lee. (2007) Soluble CD163 from activated macrophages predicts mortality in acute liver failure. Journal of Hepatology 47:5, pages 671-676.
Crossref
Crossref
Andrew P. LevyK. Raman PurushothamanNina S. LevyMeerarani PurushothamanMerav StraussRabea AslehStuart MarshOsher CohenSoren K. MoestrupHolger J. MollerElias A. ZiasDaniel BenhayonValentin FusterPedro R. Moreno. (2007) Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype. Circulation Research 101:1, pages 106-110.
Crossref
Crossref
Babs O. Fabriek, Holger J. Møller, Rianka P.M. Vloet, Lisa M. van Winsen, Roeland Hanemaaijer, Charlotte E. Teunissen, Bernard M.J. Uitdehaag, Timo K. van den Berg & Christine D. Dijkstra. (2007) Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. Journal of Neuroimmunology 187:1-2, pages 179-186.
Crossref
Crossref
K. Kowal, H. J. Møller, L. M. DuBuske, S. K. Moestrup & A. Bodzenta‐Lukaszyk. (2006) Differential expression of monocyte CD163 in single – and dual‐asthmatic responders during allergen‐induced bronchoconstriction. Clinical & Experimental Allergy 36:12, pages 1584-1591.
Crossref
Crossref
Jonas Axelsson, Holger Jon M?ller, Anna Witasp, Abdul Rashid Qureshi, Juan Jesus Carrero, Olof Heimb?rger, Peter B?r?ny, Anders Alvestrand, Bengt Lindholm, S?ren K. Moestrup & Peter Stenvinkel. (2006) Changes in Fat Mass Correlate With Changes in Soluble sCD163, a Marker of Mature Macrophages, in Patients With CKD. American Journal of Kidney Diseases 48:6, pages 916-925.
Crossref
Crossref
Holger Jon Møller, Søren K. Moestrup, Nina Weis, Christian Wejse, Henrik Nielsen, Svend Stenvang Pedersen, Jørn Attermann, Ebba Nexø & Gitte Kronborg. (2006) Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*. Critical Care Medicine 34:10, pages 2561-2566.
Crossref
Crossref
Dustin G. James, Christian D. Stone, Hanlin L. Wang & William F. Stenson. (2006) Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 12:7, pages 573-580.
Crossref
Crossref
Ida Vogel, Alice R. Goepfert, Holger J. Møller, Suzanne Cliver, Poul Thorsen & William W. Andrews. (2006) Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery. American Journal of Obstetrics and Gynecology 195:1, pages 208-214.
Crossref
Crossref
SHAHIN GAÏNI, OLE G KOLDKJÆR, SVEND S. PEDERSEN, COURT PEDERSEN, SØREN K. MOESTRUP & HOLGER J. MØLLER. (2006) Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community‐acquired infections. APMIS 114:2, pages 103-111.
Crossref
Crossref
Lina Panayiota Aristoteli, Holger Jon Møller, Brian Bailey, Søren Kragh Moestrup & Leonard Kritharides. (2006) The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 184:2, pages 342-347.
Crossref
Crossref
T.B. Knudsen, P. Gustafson, G. Kronborg, T.B. Kristiansen, S.K. Moestrup, J.O. Nielsen, V. Gomes, P. Aaby, I. Lisse, H.J. M?ller & J. Eugen-Olsen. (2005) Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clinical Microbiology and Infection 11:9, pages 730-735.
Crossref
Crossref
Ida Vogel, Jakob Grove, Poul Thorsen, Søren K. Moestrup, Niels Uldbjerg & Holger Jon Møller. (2005) Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery. BJOG: An International Journal of Obstetrics & Gynaecology 112:6, pages 737-742.
Crossref
Crossref
Mikkel Funding, Henrik Vorum, Ebba Nexø, Søren Kragh Moestrup, Niels Ehlers & Holger Jon Møller. (2005) Soluble CD163 and interleukin‐6 are increased in aqueous humour from patients with endothelial rejection of corneal grafts. Acta Ophthalmologica Scandinavica 83:2, pages 234-239.
Crossref
Crossref
Dominik J. Schaer, Boris Schleiffenbaum, Michael Kurrer, Alexander Imhof, Esther Bächli, Jörg Fehr, Holger J. Moller, Soren K. Moestrup & Andreas Schaffner. (2004) Soluble hemoglobin–haptoglobin scavenger receptor CD163 as a lineage‐specific marker in the reactive hemophagocytic syndrome. European Journal of Haematology 74:1, pages 6-10.
Crossref
Crossref
Mette Madsen, Holger J. Møller, Marianne Jensby Nielsen, Christian Jacobsen, Jonas H. Graversen, Timo van den Berg & Søren K. Moestrup. (2004) Molecular Characterization of the Haptoglobin·Hemoglobin Receptor CD163. Journal of Biological Chemistry 279:49, pages 51561-51567.
Crossref
Crossref
Anna Lis Lauridsen, Peter Vestergaard, Anne Pernille Hermann, Holger Jon Moller, Leif Mosekilde & Ebba Nexo. (2004) Female Premenopausal Fracture Risk Is Associated With Gc Phenotype. Journal of Bone and Mineral Research 19:6, pages 875-881.
Crossref
Crossref
M.J. Paidas, D.‐H.W. Ku, B. Davis, C.J. Lockwood & Y.S. Arkel. (2004) Soluble monocyte cluster domain 163, a new global marker of anti‐inflammatory response, is elevated in the first trimester of pregnancy. Journal of Thrombosis and Haemostasis 2:6, pages 1009-1010.
Crossref
Crossref
Dominique Baeten, Holger Jon Møller, Joris Delanghe, Eric M. Veys, Søren K. Moestrup & Filip De Keyser. (2004) Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis & Rheumatism 50:5, pages 1611-1623.
Crossref
Crossref
Holger Jon Møller, Maaike de Fost, Hans Aerts, Carla Hollak & Søren Kragh Moestrup. (2004) Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. European Journal of Haematology 72:2, pages 135-139.
Crossref
Crossref